BioNumerik Pharmaceuticals Company
![](/storage/logos_100px/BioNumerik Pharmaceuticals.jpg)
BioNumerik Pharmaceuticals discovers, develops and commercializes drugs for treating cancer.
Technology:
Neurological Disorders
Industry:
PharmTech
Headquarters:
San Antonio, Texas, United States
Founded Date:
1992
Employees Number:
51-100
Estimated Revenue:
$1M to $10M
Register and Claim Ownership